How many patents does
Catalyst Biosciences have?
patents
523
families
23
granted
129
applications
394
US
74
EP
57
CN
33
JP
32
KR
27
WO
12
RoW
288
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Catalyst Biosciences
Top ten assignees appearing on patents
2009 - 2018
| catalyst biosciences | 237 |
| targacept | 183 |
| attenua | 7 |
| targasept | 2 |
| catalysts biosciences | 1 |
| targcept | 1 |
| isu abxis company | 1 |
| nautilus technology | 1 |
2009
| targacept | 23 |
| catalyst biosciences | 17 |
| nautilus technology | 1 |
2018
| catalyst biosciences | 6 |
| targacept | 1 |
Catalyst Biosciences
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide,… 🛈 | 86 | 2007 |
| nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes | 70 | 2006 |
| factor vii polypeptides that are modified and uses thereof | 59 | 2008 |
| protease screening methods and proteases identified thereby | 52 | 2006 |
| nicotinic receptor non-competitive antagonists | 43 | 2010 |
| modified factor vii polypeptides and uses thereof | 39 | 2007 |
| hydroxybenzoate salts of metanicotine compounds | 34 | 2004 |
| modified factor ix polypeptides and uses thereof | 31 | 2010 |
| modified proteases that inhibit complement activation | 27 | 2005 |
| modified factor x polypeptides and uses thereof | 25 | 2012 |